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The treatment of leukemia, Hodgkin's disease and lymphosarcoma has been
advanced materially by the addition of the beta-chloroethyl amines (the nitrogen
mustards) to the other methods of therapy used in these conditions (1—4). To
this group of diseases which have a common generic term of "lymphoblastoma"
belongs the condition known as "mycosis fungoides." it is natural then that
such a drug should be used in the treatment of mycosis fungoides and already
preliminary reports (5) are appearing concerning its value.
It has been s'uggested that the method of action of the nitrogen mustards is the inactiva-
tion of the essential cellular enzymes. On the basis of various studies, it has heen shown
that the phosphokinases are highly susceptible but that this sensitivity also is found in
other types of enzymes. There is no definite correlation between susceptibility in enzyme
systems, in vivo and in vitro. Inactivation of cellular enzymes by nitrogen mustard is
probably not the primary process.
Many systemic effects can he produced in mammals by the administration of toxic
amounts of the mustards, but small doses produce pathologic changes, chiefly in cells and
tissues which are proliferating actively. As a result of the latter observation, it has been
concluded that the mustards frequently exhibit a primary nueleotoxie action and that they
net directly on the chromosomes without much influence on other cellular activities, to
produce an inheritable chromosomal abnormality. This latter effect has not been demon-
strated with any other group of chemical compounds. Roentgen and ultraviolet rays are
the only other known agents which will produce inheritable chromosomal abnormalities.
Evidence also indicates that in certain tissues, a cytoplasmic ehango occurs, which results
in necrosis of the cell. While toxic doses bring about widespread changes, minimally
effective doses evoke pathologic changes only in cells and tissues normally exhibiting a high
rate of growth and proliferation. The mitotic arrest seems confined to the resting stage of
the mitotic cycle so that the total effect is to deplete the tissuo of mitotic figures.
The marked effects of the beta-chloroethyl amines on lymphoid tissue and the obser-
vations that hyperplastie tissues are susceptible to the cytotoxic action of these compounds
suggested their therapeutic use.
The formed elements of the blood and the gastro-intestinal Inueosa are the first to reflect
the cytotoxic action of the nitrogen mustards. The action on the hematopoictie organs is
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reflected by ivuiphopenia, granulocytopenia, titrombocytopenia and anemia in the order
named. The lyinphopenia is usuaiiy apparent within twenty-four hours after the first in-
jection and is progressive for six to eight days. The count of the lyniplioeytcs usually re-
turns to normal two to three weeks after the last dose. The total count of leukocytes
declines progressively for two to three weeks after a course of treatment. This decrease
is due to neutropenia in addition to the lyniphopenia. Within three weeks after the max-
imal reduction, the neutrophil count is usually back to normal. Thrombocytopenia usually
appears during the third week after treatment; the platelet count it that time ordinarily
falls to between 60,000 and 100,000 per cubic millimeter of blood.
The effect on the gastro-intestinal system is usually apparent within four hours after an
injection and is manifested by nausea and vomiting which is seldom prolonged. These
manifestations are most noticeable after the first one or two inlections and often (10 not
appear after the later doses. Diarrhea occurs occasionally.
The form of nitrogen mustard used in this study was methyl-his (beta-chioro-
ethyl) amine hydrochloride. The drug was administered intravenously; a
single dose was 0.1 mg. per kilogram of body weight. A course of treatment
consisted of four such doses given on successive days. The decision to employ
subsequent courses depended on the clinical response, the condition of the
patient and the status of the hematopoietic system. Additional courses were
not given sooner than six weeks after the preceding course. The individual doses
which our patients received varied from 4.5 to 8.5 mg.
CASE REPORTS
To date we have treated six patients who had mycosis fungoides with nitrogen
mustard. Three of the patients have had two courses of the drug. One patient
died of a febrile illness unexplained on necropsy two weeks after a course of
treatment with nitrogen mustard was given. This patient had never received
roentgen therapy. The infiltrated plaques of mycosis fungoides showed regres-
sion within one week after the completion of the course of treatment.
Another patient (fig. 1) because of pregnancy, received roentgen therapy to
all the skin except that on the lower part of the back and abdomen. Benefit
was noted in all irradiated regions. One month after roentgen therapy, a nor-
mal infant was delivered. Two weeks later a course of treatment with nitrogen
mustard was given. Within two days after completion of this course of treat-
ment, the pruritus improved and within a week there was regression in the size
and degree of infiltration of the tumors in the regions which had not been treated
with radiation. The patient returned two and a half months later for another
examination. Although her condition was improved as compared with that
on the original examination, there were new tumors and recurrence of nodules
in some regions. She then was given a second course of nitrogen mustard.
Four of the patients in this group had received repeated courses of roentgen
therapy over a period of one to six years. The plaques and tumors of mycosis
fungoides had become resistant to radiation in these cases and for this reason
nitrogen mustard was administered. The results of treatment in one case were
striking. The patient rapidly gained in strength and weight, while the pain
and pruritus almost completely disappeared. The infiltration and erythema
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of the skin rapidly subsided so that she was able to return home alter Continuous
hospitalization for ten months. She returned for a second course of nitrogen
mustard six weeks later. At this time her general condition was still improving
but the paroxysmal pruritus had recurred. The general condition and cutaneous
lesions of the three other patients improved after treatment with nitrogen mus-
FIG. la. Before treatment with nitrogen mustard. Note the delineated area across the
lumbar region exhibiting the improvement (on the left) from roentgen therapy six weekspreviously. No roentgen therapy was given to the aeral area and buttock. 5. Two
and a half months after treatment with nitrogen mustard. The resolution of the tumors
of mycosis fungoides is evident. There had been a recurrence of lesions in other areas.
tard. One patient who had two courses of treatment reported increased pruritus
following the second course after having had relief of pruritus after the first
course. However, the lesions of mycosis fungoides were disappearing and there
were no new lesions two months after the second course. Relief of pruritus was
great in the other two cases one to two and a half months after treatment. They
did not have any new lesions and improvement in the original lesions continued
(fig. 2). As this paper was being finished, two patients returned two and seven
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weeks, respectively, after the original follow-up. Both have had mild recur-
rences of infiltrated plaques, and moderate pruritus.
Four of our six patients had universal exfoliative erythroderma in addition
to the other evidences of mycosis fungoides. Following treatment with nitro-
gen mustard the exfoliative dermatitis improved rapidly in two eases and slowly
in two. Improvement in the generalized eruption did not begin as soon as,
or progress as rapidly as, the improvement in the infiltrated plaques and tumors,
although relief of pruritus was the first beneficial effect noted by most patients.
Fin. 2e. Before treatment with nitrogen mustard. b, Two and a half months after
treatment with nitrogen mustard. Note the almost complete disappearance of the infil-
trated plaques. Excoriations are less.
Reactions to nitrogen mustard in our eases were essentially of the gastro-
intestinal type. All patients had nausea after the first injection and four had
vomiting within three hours after the first injection. As the injections were
continued daily, the nausea and vomiting tended to become less severe; however,
it was necessary to discontinue the daily injections in two eases because of the
severity of the reaction. Diarrhea occurred in one patient. Pyridoxine ad-
ministered intravenously seemed of some value in decreasing the severity of
nausea and vomiting.
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Disturbances of the formed elements of the blood are seen frequently in pa-
tients treated with nitrogen mustard. In our patients leukopenia, granulo-
cytopenia and thrombocytopenia occurred. However, in no instance did the
count of the leukocytes drop to less than 2,500 per cubic millimeter of blood.
In one case the platelet count fell to 48,000 per cubic millimeter but
rose promptly. No patient required treatment because of the temporary sup-
pression of the function of the hematopoietic system. In those patients whom
we were able to follow closely for some time, the factors of the blood became nor-
mal three to four weeks after treatment. In no patient was it necessary to
discontinue therapy for more than two days because of any untoward reaction.
In four cases in which specimens for biopsy were taken before treatment
was instituted, histopathologic changes were typical for mycosis fungoides in
either the infiltrated or tumor stage. There was no histologic evidence of
lymphosarcoma or Hodgkin's disease. Biopsy of specimens taken at varying
intervals after treatment with nitrogen mustard revealed relatively little change
in the histologic picture on comparison with the picture before treatment. No
correlation could be made between the histologic picture and the degree of clinical
improvement.
In one case there was some decrease of the infiltrate with some increase of
pyknosis and karyorrhexis of the cells two weeks after treatment. In two other
cases, specimens for biopsy, taken late after treatment (seven weeks and two and
a half months), still showed clear-cut evidence of mycosis fungoides and little
change was noted in the character of the infiltrate. In one case a third biopsy
one day after a second course of treatment disclosed no appreciable change in
the degree of infiltrate or in the character of the individual cells as compared to
observations made at the first biopsy and at one made two and a half months
after the first course of treatment.
It is obvious that an adequate histologic study of the therapeutic influence of
nitrogen mustard on the lesions of mycosis fungoides must entail more biopsies
from the same lesion and similar lesions at more frequent intervals in order to
attempt to determine the period of maximal therapeutic response and the average
duration of remissions.
COMMENT
Treatment of mycosis fungoides by means of methyl-bis (beta-chloroethyl)
amine hydrochloride appears to produce the same effect and to bring about the
same clinical result as does roentgen therapy. Goodman and his associates
(6) have suggested that responsiveness to therapy by radiation occasionally
may be restored after a course of treatment with nitrogen mustard. We have
not been able to demonstrate this because of the limited period of observation
in our cases. Yet it is apparent that nitrogen mustard is an adjunct to therapy
when the lesions of mycosis fungoides have become resistant to reontgen therapy.
No patient was treated with both nitrogen mustard and roentgen rays at the
same time; in one case nitrogen mustard was given six weeks after an intensive
course of irradiation without any more untoward reaction than one would expect
from the drug alone.
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The gastro-intestinal reactions from nitrogen mustard are more acute and at
times more severe than is seen with roentgen therapy; yet the patients recover
more rapidly from their reactions. It seems too, that the recovery of the hemato-
poietic system is more rapid after treatment with nitrogen mustard than after
radiation.
It is impossible from this study to determine the duration of remissions pro-
duced by treatment with nitrogen mustard. In two of our patients they have
lasted slightly more than two months and in one more than four months. How-
ever, two of these three patients had two courses of treatment. It is probable
that longer remissions will be seen as the period of observation lengthens.
Whether or not remissions from the use of nitrogen mustard will be as lasting
as those produced by radiation is a question that cannot be answered by the
material available at present.
The first evidence of benefit noted by the patient was a diminishing of the
pruritus followed shortly by an increase of the sense of well-being. Usually
within a week after the last injection the tumors and nodules became softer, as
did the infiltrated plaques. The erythroderma became less vividly colored and
assumed a dull hue.
SUMMARY AND CONCLUSIONS
Methyl-bis (beta-chioroethyl) amine hydrochloride (nitrogen mustard) has
been used for the treatment of mycosis fungoides in six patients. In four of
these patients the condition had become resistant to roentgen therapy.
One patient died of apparently unrelated causes shortly after a course of
nitrogen mustard was given. The general condition and the cutaneous lesions
of the other five patients improved significantly after treatment. Three pa-
tients have had two courses of the drug.
The duration of remissions obtained with this therapy are impossible to predict
but in one patient a remission of more than four months' duration has been
Obtained.
Reactions are frequent, acute and occasionally severe; but in all cases it was
possible to complete a course of therapy without serious ill-effects.
The limited histopathologic findings indicate to us that the response of the
individual lesions in the same individual and of lesions of different individuals
to therapy with nitrogen mustard will vary greatly.
Nitrogen mustard in the treatment of mycosis fungoides is an adjunct to pre-
viously recognized therapeutic measures and is of particular value when roentgen
therapy is no longer of benefit.
Dr. Louis H. Winer: I have seen histologic skin sections of patients with mycosis fun.
oides, after they were treated with nitrogen mustard. Although the histopathologic pic-
ture was still definitely mycosis fungoides, there was exaggerated liquefaction necrosis
of the proliferating reticulum cells.
Closing Discussion by Dr. Robert I?. Kiertand: I thank Doctor Winer for his interesting
discussion. A wave of enthusiasm is spreading rapidly concerning the use of these chem-
&cal agents. The fact that these agents are toxic must be kept constantly in mind. As time
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goes on and as more cases are studied, more and more will be learned of the indications for
and the action of these nitrogen mustards, but until that time is reached the physician
should use these preparations cautiously. Urethane and other drugs will soon become
available for the treatment of lymphoblastomatous conditions, and the same word8 of cau-
tion I have just mentioned are applicable for these therapeutic agents.
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